OKYO
OKYO Pharma
OKYO
OKYO
7 hedge funds and large institutions have $176K invested in OKYO Pharma in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+6
Holders Change %
+600%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$46K |
| 2 |
Renaissance Technologies
New York
|
+$30K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$29.5K |
| 4 |
Morgan Stanley
New York
|
+$25.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.4K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| $46K | +$46K | +25,000 | New |
|
|
2
Renaissance Technologies
New York
| $30K | +$30K | +16,347 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $29.5K | +$29.5K | +15,943 | New |
|
|
4
Morgan Stanley
New York
| $25.6K | +$25.6K | +13,846 | New |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $22.4K | +$22.4K | +12,090 | New |
|
6
HSBC Holdings
London,
United Kingdom
| $22.1K | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $176 | +$176 | +95 | New |
|